These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 25765813)

  • 1. Involvement of microsomal NADPH-cytochrome P450 reductase in metabolic reduction of drug ketones.
    Lehr M; Fabian J; Hanekamp W
    Biopharm Drug Dispos; 2015 Sep; 36(6):398-404. PubMed ID: 25765813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigations on the metabolic stability of cytosolic phospholipase A2α inhibitors with 1-indolylpropan-2-one structure.
    Fabian J; Hanekamp W; Thomas MH; Olivier JL; Lehr M
    Chem Biol Interact; 2013 Nov; 206(2):356-63. PubMed ID: 24120545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-Heteroaryl-3-phenoxypropan-2-ones as inhibitors of cytosolic phospholipase A₂α and fatty acid amide hydrolase: Effect of the replacement of the ether oxygen with sulfur and nitrogen moieties on enzyme inhibition and metabolic stability.
    Sundermann T; Fabian J; Hanekamp W; Lehr M
    Bioorg Med Chem; 2015 May; 23(10):2579-92. PubMed ID: 25862211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NADPH-flavodoxin reductase and flavodoxin from Escherichia coli: characteristics as a soluble microsomal P450 reductase.
    Jenkins CM; Waterman MR
    Biochemistry; 1998 Apr; 37(17):6106-13. PubMed ID: 9558349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol to pyridinium metabolites.
    Avent KM; DeVoss JJ; Gillam EM
    Chem Res Toxicol; 2006 Jul; 19(7):914-20. PubMed ID: 16841959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reductive metabolism of an alpha,beta-ketoalkyne, 4-phenyl-3-butyn-2-one, by rat liver preparations.
    Kitamura S; Kohno Y; Okamoto Y; Takeshita M; Ohta S
    Drug Metab Dispos; 2002 Apr; 30(4):414-20. PubMed ID: 11901095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative Evaluation of the Contribution of Each Aldo-Keto Reductase and Short-Chain Dehydrogenase/Reductase Isoform to Reduction Reactions of Compounds Containing a Ketone Group in the Human Liver.
    Ichida H; Fukami T; Amai K; Suzuki K; Mishiro K; Takano S; Obuchi W; Zhang Z; Watanabe A; Nakano M; Watanabe K; Nakajima M
    Drug Metab Dispos; 2023 Jan; 51(1):17-28. PubMed ID: 36310032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Denitrosation of the anti-cancer drug 1,3-bis(2-chloroethyl)-1-nitrosourea catalyzed by microsomal glutathione S-transferase and cytochrome P450 monooxygenases.
    Weber GF; Waxman DJ
    Arch Biochem Biophys; 1993 Dec; 307(2):369-78. PubMed ID: 8274024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes.
    Yamazaki H; Nakano M; Imai Y; Ueng YF; Guengerich FP; Shimada T
    Arch Biochem Biophys; 1996 Jan; 325(2):174-82. PubMed ID: 8561495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-electron reduction of mitomycin c by rat liver: role of cytochrome P-450 and NADPH-cytochrome P-450 reductase.
    Vromans RM; van de Straat R; Groeneveld M; Vermeulen NP
    Xenobiotica; 1990 Sep; 20(9):967-78. PubMed ID: 2122607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human microsomal carbonyl reducing enzymes in the metabolism of xenobiotics: well-known and promising members of the SDR superfamily.
    Skarydová L; Wsól V
    Drug Metab Rev; 2012 May; 44(2):173-91. PubMed ID: 22181347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of microsomal NADPH-cytochrome P-450 reductase and cytochrome P-450IVA1 (P-450LA omega) by dehydroepiandrosterone in rats: a possible peroxisomal proliferator.
    Wu HQ; Masset-Brown J; Tweedie DJ; Milewich L; Frenkel RA; Martin-Wixtrom C; Estabrook RW; Prough RA
    Cancer Res; 1989 May; 49(9):2337-43. PubMed ID: 2523237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anthracyclines and their metabolism in human liver microsomes and the participation of the new microsomal carbonyl reductase.
    Skarka A; Skarydová L; Stambergová H; Wsól V
    Chem Biol Interact; 2011 May; 191(1-3):66-74. PubMed ID: 21185270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of carbonyl reduction in subcellular fractions and different organs in rodents.
    Oppermann UC; Maser E; Mangoura SA; Netter KJ
    Biochem Pharmacol; 1991 Dec; 42 Suppl():S189-95. PubMed ID: 1768277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of reductive metabolism in human intestine and quantitative prediction of intestinal first-pass metabolism by cytosolic reductive enzymes.
    Nishimuta H; Nakagawa T; Nomura N; Yabuki M
    Drug Metab Dispos; 2013 May; 41(5):1104-11. PubMed ID: 23444387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzymology of a carbonyl reduction clearance pathway for the HIV integrase inhibitor, S-1360: role of human liver cytosolic aldo-keto reductases.
    Rosemond MJ; St John-Williams L; Yamaguchi T; Fujishita T; Walsh JS
    Chem Biol Interact; 2004 Mar; 147(2):129-39. PubMed ID: 15013815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human hepatic and renal microsomes, cytochromes P450 1A1/2, NADPH:cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid-DNA adducts found in patients with urothelial cancer.
    Stiborová M; Frei E; Hodek P; Wiessler M; Schmeiser HH
    Int J Cancer; 2005 Jan; 113(2):189-97. PubMed ID: 15386410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro metabolism of the phosphatidylinositol 3-kinase inhibitor, wortmannin, by carbonyl reductase.
    Holleran JL; Fourcade J; Egorin MJ; Eiseman JL; Parise RA; Musser SM; White KD; Covey JM; Forrest GL; Pan SS
    Drug Metab Dispos; 2004 May; 32(5):490-6. PubMed ID: 15100170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for requirement of NADPH-cytochrome P450 oxidoreductase in the microsomal NADPH-sterol Delta7-reductase system.
    Nishino H; Ishibashi T
    Arch Biochem Biophys; 2000 Feb; 374(2):293-8. PubMed ID: 10666310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of enzymes of drug metabolism in rat liver by ultrasound and correction by heparin.
    Legonkova LF; Bushma MI; Zverinsky IV; Eismont KA
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):360-2. PubMed ID: 10445398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.